Lojaimiess Blister
Lojaimiess Kit
Product Images NDC 70700-124
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lojaimiess (NDC 70700-124). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Xiromed, Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Lojaimiess Carton
This is a description of an extended-cycle oral contraceptive product in which one unit or dispenser contains 91 tablets, comprising of 84 orange tablets, each containing 0.1 mg levonorgestrel and 0.02 mg ethinyl estradiol, and 7 yellow tablets, each containing 0.01 mg ethinyl estradiol. It explicitly states that the product is intended to prevent pregnancy but does not protect against HIV infection or other sexually transmitted diseases. The recommended dosage is one orange tablet per day for four consecutive days, followed by one yellow tablet for the consequent seven days as per a prescribed schedule. The package label also provides information about storage conditions.*
Lojaimiess Levonorgestrel
Lojeimeiss Bar Chart
This appears to be a chart showing the percentage of bleeding and/or spotting occurring during different cycles over a span of 364 days. There were 848 participants in the first cycle and 574 in the fourth cycle.*
Lojeimeiss Chart
This text appears to be a chart comparing different methods of birth control and their effectiveness in preventing pregnancy. It indicates the number of pregnancies per 100 women in one year for each method. The most effective forms are listed at the top, including sterilization, intrauterine devices, birth control implants, and injections. Less effective methods such as birth control pills, condoms, and withdrawal are listed below. The chart also mentions the possibility of not having sex during the most fertile days of the monthly cycle, using spermicide, or using a diaphragm. However, the text at the bottom is cut off and therefore the chart may not provide the full information on all methods.*
Lojeimeiss Effect Estimate
Lojeimeiss Ethinyl Estradiol
Ethinyl Estradiol is a compound with the molecular formula C20H24O2 and a molecular weight of 296.4. It is commonly used as a medication in hormonal birth control pills.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
